Publix recognized on Fortune’s Best Companies to Work For list
For 29 consecutive years, the grocer has been recognized by Fortune as a great place to work.
For 29 consecutive years, the grocer has been recognized by Fortune as a great place to work.
New collection drops in stores nationwide starting in April.
A new skincare brand from Hyundai Bioscience brings peptide-driven barrier care to mass-market price points, with all products under $25.
As detailed in the HDA Research Foundation’s 2025 Specialty Pharmaceutical Distribution Facts, Figures and Trends, specialty distributors are meeting the greater demand through innovation and coordination across the healthcare supply chain.
The new razor was specifically engineered to navigate the unique challenges men face when shaving their body and address the top concerns men have when body grooming including fear of nicks, cuts or irritation.
Available in three new flavors in a 12-oz sleek can.
GenieRx will serve as the "stalking horse bidder" in the company's ongoing court‑supervised sale process.
The series, available on Hamacher.com, features Georgia Gums, product & strategic pricing analyst.
Oral GLP-1 therapy achieves double-digit weight loss in trials and launches this month with no food or water restrictions, expanding access through retail and direct-to-consumer channels.
For L’Oréal, the acquisition adds another jewel to its growing luxury portfolio, which already includes Yves Saint Laurent Beauté, Lancôme, and Aesop, acquired in 2023.
Low-cost screenings administered by registered dietitians are available at more than 100 Hy-Vee stores.
Advanced automation and connected data capabilities strengthen medication inventory control and enhance safety across pharmacy settings.
Move to support growing demand for novel cancer therapies
The limited time offering will be available at all four New York Avo locations and online starting today, March 31st through June 30th.
This collaboration helps health systems simplify operations, lower program costs, and reduce vendor complexity so their programs can grow more sustainably.
Nelson Ambrogio, currently president of Bayer’s global Radiology business, will be appointed president of Bayer U.S. Pharmaceuticals.